Te AE - Search Results

1

Comparison of techniques for transurethral laser prostatectomy: standard photoselective vaporization of the prostate versus transurethral laser enucleation of the prostate.

Elterman DS, Chughtai B, Lee R, Kurlander L, Yip-Bannicq M, Kaplan SA, Te AE. Elterman DS, et al. Among authors: te ae. J Endourol. 2013 Jun;27(6):751-5. doi: 10.1089/end.2012.0561. Epub 2013 Feb 21. J Endourol. 2013. PMID: 23268717

2

Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index?

Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA. Choi J, et al. Among authors: te ae. Eur Urol. 2002 Jul;42(1):7-11. doi: 10.1016/s0302-2838(02)00222-1. Eur Urol. 2002. PMID: 12121722

3

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Among authors: te ae. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

4

How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy?

Gonzalez RR, Te AE. Gonzalez RR, et al. Among authors: te ae. Curr Urol Rep. 2003 Aug;4(4):297-306. doi: 10.1007/s11934-003-0088-x. Curr Urol Rep. 2003. PMID: 12882722 Review. No abstract available.

5

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Kaplan SA, Volpe MA, Te AE. Kaplan SA, et al. Among authors: te ae. J Urol. 2004 Jan;171(1):284-8. doi: 10.1097/01.ju.0000101487.83730.80. J Urol. 2004. PMID: 14665895 Clinical Trial.

6

The development of laser prostatectomy.

Te AE. Te AE. BJU Int. 2004 Feb;93(3):262-5. doi: 10.1111/j.1464-410x.2004.04598.x. BJU Int. 2004. PMID: 14764119 Review. No abstract available.

7

Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Te AE, et al. J Urol. 2004 Oct;172(4 Pt 1):1404-8. doi: 10.1097/01.ju.0000139541.68542.f6. J Urol. 2004. PMID: 15371855 Clinical Trial.

8

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

9

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. Among authors: te ae. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

10

Photoselective laser vaporization prostatectomy in men receiving anticoagulants.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: te ae. J Endourol. 2005 Dec;19(10):1196-8. doi: 10.1089/end.2005.19.1196. J Endourol. 2005. PMID: 16359214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters